Rapid Micro Biosystems Inc expected to post a loss of 24 cents a share - Earnings Preview
Rapid Micro Biosystems Inc
RPID is expected to show a rise in quarterly revenue when it reports results on October 30 (estimated) for the period ending September 30 2025The Lexington Massachusetts-based company is expected to report a 1.9% increase in revenue to $7.75 million from $7.6 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
LSEG's mean analyst estimate for Rapid Micro Biosystems Inc is for a loss of 24 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Rapid Micro Biosystems Inc is $8.00, about 63.1% above its last closing price of $2.95
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2025 | -0.24 | -0.25 | -0.27 | Missed | -6.6 |
Mar. 31 2025 | -0.27 | -0.27 | -0.26 | Beat | 3.7 |
Dec. 31 2024 | -0.23 | -0.23 | -0.22 | Beat | 4.3 |
Sep. 30 2024 | -0.25 | -0.26 | Missed | -2 | |
Jun. 30 2024 | -0.28 | -0.28 | -0.29 | Missed | -4.8 |
Mar. 31 2024 | -0.29 | -0.29 | -0.31 | Missed | -6.9 |
Dec. 31 2023 | -0.30 | -0.30 | -0.26 | Beat | 13.3 |
Sep. 30 2023 | -0.30 | -0.31 | -0.31 | Met | -1.1 |
This summary was machine generated October 28 at 13:58 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
